NEW
BRUNSWICK, N.J., Dec. 7, 2022
/PRNewswire/ -- Pipeline Medical, a MedTech marketplace
focused on supplying pharmaceuticals and medical supplies to
medical professionals around the country, recently announced the
addition of Jeuveau® (prabotulinumtoxinA-xvfs) by Evolus, Inc.
(NASDAQ: EOLS).
Launched in 2019, Jeuveau® is a botulinum toxin type A, a
prescription medicine that is injected into muscles and used in
adults for a short period of time (temporary) to improve the look
of moderate to severe frown lines between the eyebrows (glabellar
lines).
"Pipeline Medical was founded by aesthetic practitioners; as
such, we are always looking to provide our customers with the best
products in the market. Today we are thrilled to offer Jeuveau® to
our customers. Jeuveau® is a top-performing toxin, dedicated
strictly to aesthetics, available at an unbeatable price point,"
says Zachary Ducharme, CEO, of
Pipeline Medical.
As a MedTech marketplace, Pipeline Medical aggregates medical
supplies and pharmaceuticals from multiple manufacturers,
suppliers, and distributors. Providing customers with a
one-stop-shop and streamlined purchasing experience. Pipeline's
consistency in product availability at low prices has led Pipeline
Medical to tremendous growth in the past decade.
Pipeline Medical caters to many highly influential plastic
surgeons, medical spas, dermatologists, and aesthetic practices
around the country.
"At Evolus, our goal is to help providers reach the next
generation of consumers with a precise product and a unique
business model," said Kurt Knab, SVP
of Sales at Evolus. "We look forward to partnering with
Pipeline Medical to increase access to Jeuveau and expand adoption
among a large and impactful group of providers." Along with
the product benefits, Pipeline Medical looks forward to offering
its customers Evolus' co-branded marketing model. The co-branded
marketing model offers customers a wide range of advertising
options, including digital ads, billboards, and most recently,
streaming television advertisements, with a direct call to action
to book appointments using a smartphone and QR code.
Jeuveau® is the highest-selling aesthetic product launched since
2019, with sales to more than 8,800 practices nationwide and a
reorder rate of over 70 percent. These practices have administered
more than 2 million treatments of Jeuveau® to date.
Pipeline Medical has gained the trust of plastic surgeons and
physicians for its mastery of supply chain management and ability
to offer 20-40% discounts on medical supplies. Even during the
height of the pandemic, the company shipped essential products and
medical supplies around the country with excellent efficiency.
Pipeline Medical offers a wide range of products, including
surgical instruments, sutures, medical supplies, surgical supplies,
and pharmaceuticals. The company is constantly innovating and
introducing new products that make the lives of medical providers
easier.
About Pipeline Medical
Pipeline Medical is a single-source medical supply provider
serving non-acute customers by acting as a GPO, distributor, and
material manager, providing medical practitioners with significant
savings of time and money.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving
the aesthetic neurotoxin market for the next generation of beauty
consumers through its unique, customer-centric business model and
innovative digital platform. Its mission is to become a global,
multi-product aesthetics company based on its flagship product,
Jeuveau® (prabotulinumtoxinA-xvfs), the first and only
neurotoxin dedicated exclusively to aesthetics and manufactured in
a state-of-the-art facility using Hi-Pure™ technology.
Contact:
Zachary Ducharme
CEO of Pipeline Medical
zducharme@pipelinemedical.com
+1 (646) 887-7059
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leading-medtech-marketplace-pipeline-medical-now-provides-jeuveau-by-evolus-inc-301692550.html
SOURCE PIPELINE MEDICAL